abstract |
The present invention relates to formula (I): [Chemical 1] [Wherein Z is (A) or (B): [Chemical formula 2] And other variable symbols are as defined in the specification], methods for the preparation of such compounds, and the use of such compounds in the treatment of chemokines (such as CCR3) or H1-mediated conditions. |